期刊文献+

肝切除术患者围术期高血糖相关因素分析及乌司他丁的干预作用 被引量:6

The related factors of perioperative hyperglycemia during hepatectomy and the effect of ulinastatin on perioperative blood glucose
在线阅读 下载PDF
导出
摘要 目的探讨肝切除术患者围术期高血糖发生的相关因素及乌司他丁对围术期血糖的影响。方法择期肝脏部分切除术患者70例,随机均分为两组,分别于麻醉开始时及手术开始时给予乌司他丁20万单位(U组)或等量生理盐水20ml(C组)。于手术切皮前(T1)、切肝前(T2)、切除病肝后20min(T3)、关闭腹腔后(T4)、术后第1天清晨(T5)和第2天清晨(T6)监测血糖。对年龄、手术切皮前空腹血糖值、术中出血量、手术时间、手术切除范围、是否进行术后镇痛、有无糖尿病病史与L时空腹血糖进行多元逐步回归分析。结果C组血糖在T1时最低,T2时逐步上升,T3~T5时达到高峰,T6时下降。U组血糖在T1时最低,T4时达高峰,T6时下降。T2~T6时C组血糖明显高于U组(P〈O.01)。T5时C组空腹血糖与术中出血量、手术切除范围、术前糖尿病史存在独立的正相关关系,回归方程R^2为0.827(P〈0.05)。结论肝切除术围术期高血糖的发生与术中出血量、手术切除范围、术前糖尿病史相关,乌司他丁对于这种高血糖反应具有显著改善作用。 Objective To explore the related factors of perfoperative hyperglycemia in patients undergoing hepatectomy and the effect of ulinastatin on perfoperative hlood glucose. Methods Seventy patients undergoing selective hepatectomy were chosen and randomly divided into the control group (group C) and the experimental group(group U). The patients in group U were injected ulinastatin 200,000 units before anesthesia and be{ore surgery respectively. We measured the blood glucose at six time points including the time prior to skin incision (T1), the time prior to hepatectomy (T2), 20 minutes after liver lesion removed(T3), the time right after closing the abdominal cavity(T4 ), the next morning after surgery(T5), and the second morning after surgery(T6 ). The clinical data of group C: age, the value of fasting blood glucose (FBG) before skin cutting, the amount of intraoperative blood loss, the duration and the extent of surgery, the application of postoperative analgesia, and the history of diabetes with the FBG in the first postoperative morning were analyzed for multiple stepwise regression analysis. Results In group C, the FBG value increased gradually from its bottom in T1 and showed a downward trend in T8 after reached its peak in T3-T5. In group U, the FBG value increased gradually from its bottom in T1 and returned to preoperative level in T6 after reached its peak in T4. The FBG value was higher in group C compared with group U in all time points except T1. The FBG of the patient in group C in the first postoperative morning had independent correlativity among the intraoperative blood loss, the extent of surgical resection as well as the history of diabetes, and the 172 of regression equation was 0. 827 (P〈0.05). Conclusion The hyperglycemia happened in the perfoperative period of hepatectomy had correlation with the amount of intraoperative blood toss, the extent of surgical resection and the history of diabetes. Additionally, ulinastatin can ameliorate this hyperglycemia.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2013年第12期1167-1170,共4页 Journal of Clinical Anesthesiology
基金 天普研究基金资助项目(编号:01201036)
关键词 围术期 血糖 乌司他丁 肝切除术 Perfoperative period Blood glucose Ulinastatin Hepatectomy
  • 相关文献

参考文献10

  • 1Akhtar S, Barash PG, Inzucchi SE. Scientific principles andclinical implications of perioperative glucose regulation and control. Anesth Analg,2010,110(2) :478-497.
  • 2Bagry HS, Raghavendran S, Carli F. Metabolic syndrome and insulin resistance: perioperative considerations. Anesthe- siology, 2008,108(3) : 506-523.
  • 3卢欣,毛一雷,桑新亭,杨志英,钟守先,黄洁夫.乌司他丁对不同范围肝脏切除影响的前瞻性临床研究[J].中华普通外科杂志,2005,20(11):727-729. 被引量:8
  • 4Park KH, Lee KH, Kim H, et al. The anti-inflammatory effects of ulinastatin in trauma patients with hemorrhagic shock. J Korean Med Sci, 2010,25(1):128-134.
  • 5Biddinger SB, Kahn CtL From mice to mere insights into the in- sulin resistance syndromes. Annu Rev Physiol, 2006, 68: 123-158.
  • 6严六狮,袁慧,王伟,李小刚,刘齐宁.乌司他丁对腹腔镜直肠癌手术围术期炎性反应的影响[J].临床麻醉学杂志,2012,28(8):756-758. 被引量:19
  • 7应俊,华福洲,胡衍辉,卢忆梅,徐国海.乌司他丁对肝脏肿瘤切除术患者肝脏缺血-再灌注损伤的保护作用[J].临床麻醉学杂志,2012,28(5):421-423. 被引量:11
  • 8NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critical- ly ill patients. N Engl J Med, 2009,360(13) : 1283-1297.
  • 9Egi M, Bellomo R, Stachowski E, et al. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology, 2006,105(2) :244-252.
  • 10Krinsley JS. Glycemic variability: a strong independent pre- dictor of mortality in critically ill patients. Crit Care Med, 2008,36(11) :3008 -3013.

二级参考文献27

  • 1毛一雷,于卓,卢欣,桑新亭,杨志英,钟守先.AG490提高极限肝切除术后大鼠存活率的机制[J].中国医学科学院学报,2005,27(1):73-76. 被引量:8
  • 2于金玲,朱江帆.腹腔镜手术CO_2气腹导致的肝缺血再灌注损伤及其对策[J].中国微创外科杂志,2007,7(1):67-69. 被引量:17
  • 3Okuhama Y, Shiraishi M, Higa T, et al. Protective effects of ulinastatin against ischemia-reperfusion injury. J Surg Res, 1999,82:34-42.
  • 4Laterre PF, Heiselman D. Management of patients with severe sepsis treated by drotrecogin alfa (activated). Am J Surg, 2002,184 :S39-46.
  • 5Clergur F,Morel P,Pastor CM. Perioperative management of patients with increased risk of laparoscopy-induced hepatic hypoperfusion. Swiss Med Wkly,2004,134(3-4) :39-43.
  • 6Diebel LN, Dulehavsky SA, Saxe J. Effect of increased intra- abdominal pressure on hepatic arterial, portal venous, and he patic microcirculatory blood flow. J Trauma, 1992, 33 (2) : 279-283.
  • 7Takagi S. Hepatic and portal vein blood flow during carbond- ioxide pneumoperitoneuw for laparoseopic hepatectomy. Surg Endosc, 1998, 12(2):427-431.
  • 8Nouman J. The role of cytokine in the pathogenesis of acute panereatitis. Am Surg, 1998,175 ( 1 ) : 76 83.
  • 9Inoue K,'Fakano H,Shimada A, et al. Urinary trypsin inhibi tor protects against systemic inflammation induced by lipopo lysaccharide. Mol Pharmacol,2005,67(3) : 673-680.
  • 10Teoh NC. Hepatic ischemia reperfusion injury:Contemporary perspectives on pathogenic mechanisms and basis for hepatoprotection-the good,bad and deadly[J].J Gastroenterol Hepa tol,2011.180-187.

共引文献35

同被引文献64

  • 1Yifei Zhao,Yuelun Zhang,Le Shen,Yuguang Huang.Effect of intra-operative hyperglycemia and insulin treatment on post-operative neutrophil counts:a retrospective observational study[J].Chinese Medical Journal,2023,136(17):2134-2136. 被引量:1
  • 2刘合利,杨连粤.根据术前肝脏储备功能选择肝切除术式[J].肝胆外科杂志,2007,15(2):87-88. 被引量:6
  • 3Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet, 2009, 373(9677):1798-1807.
  • 4Bower WF, Lee PY, Kong APS, et al. Peri-operative hyper- glycemia: a consideration for general surgery? Am J Surg, 2010, 199(2) :240-248.
  • 5Freise H, Van Aken HK. Risks and benefits of thoracic epi- dural anaesthesia. Br J Anaesth, 2011, 107(6) : 859-868.
  • 6Greisen J, Nielsen DV, Sloth E, et al. High thoracic epidural analgesia decreases stress hyperglycemia and insulin need in cardiac surgery patients. Acta Anaesthesiol Seand, 2013, 57 (2) :171-177.
  • 7Wen SH, Ling YH, Li Y, et ak Ischemic postconditioning during reperfusion attenuates oxidative stress and intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion via aldose reduetase. Surgery, 2013, 153(4):555- 564.
  • 8Wamelink M, Sruys E, Jakobs C. The biochemistry, metab- olism and inherited defects of the pentose phosphate pathway: a review. J Inherit Metab Dis, 2008, 31(6):703-717.
  • 9Kouraklis G, Glinavou A, Raftopoulos L, et al. Epidural an- algesia attenuates the systemic stress response to upper ab dominal surgery: a randomized trial. Int Surg, 2000, 85(4): 353- 357.
  • 10Olle Ljungqvist.Insulin Resistance and Outcomes in Surgery[J]. The Journal of Clinical Endocrinology & Metabolism . 2010 (9)

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部